Legal Representation
Attorney
Philip R. Zender
USPTO Deadlines
Next Deadline
1290 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230711)
Due Date
July 11, 2029
Grace Period Ends
January 11, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 11, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jul 11, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 25, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 25, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 5, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 17, 2023 | FIXD | O | ELECTRONIC RECORD REVIEW COMPLETE | Loading... |
| Mar 10, 2023 | ERRR | O | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | Loading... |
| Mar 7, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 3, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 2, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 2, 2023 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Sep 29, 2022 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Sep 29, 2022 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Sep 29, 2022 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Sep 28, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 27, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 27, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 1, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 1, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 1, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 29, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 16, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 13, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Preparations and substances for use in the treatment of genetic deficiencies or disorders, diseases, infectious diseases, immune system-related diseases or immune system-mediated disorders and metabolic diseases and disorders, cancers, cardiovascular diseases and disorders, hematologic diseases and disorders, neurologic diseases and disorders, skeletal muscular diseases and disorders, pulmonary diseases and disorders, gastrointestinal diseases and disorders and aging
Class 040
Custom manufacturing of pharmaceutical preparations and substances for others; manufacturing services in the field of cell and gene therapy, namely, manufacturing and processing of viral and non-viral gene vectors, proteins, peptides, antibodies and DNA to order and/or specification of others
Class 042
Medical research and development services in the field of gene therapy and genetic medicine; scientific research and development; and pharmaceutical research and development
Additional Information
Pseudo Mark
ENGINE
Classification
International Classes
005
040
042